Research peptide · For research purposes only
Growth hormone, muscle & body composition research
Educational research guide only. To compare companies that offer CJC-1295, open the Products page — scores belong to sellers, not this compound as a whole.
Growth hormone, muscle & body composition research
CJC-1295 is a growth hormone–releasing hormone (GHRH) analog studied for GH-axis signaling. Catalog listings may specify DAC or no-DAC forms. For research purposes only.
Also known as: Modified GRF (generic listing) · Modified GRF 1-29 · CJC-1295 DAC · CJC-1295 no DAC
CJC-1295 is a synthetic GHRH analog. Some preparations include a Drug Affinity Complex (DAC) moiety that can change half-life characteristics in experimental systems; others are sold as “no DAC” / modified GRF 1-29 variants. Researchers compare forms carefully because identity and labeling matter for reproducibility.
Vendors should clearly label whether a vial is CJC-1295 with DAC or without. Mislabeling is a common transparency complaint in community reviews.
CJC-1295 research materials are not FDA-approved consumer medicines. Educational content only.
Companies on PurityWatch may list CJC-1295 as a compound they offer for research. Listing a compound does not mean it is approved for human use.
DAC-containing analogs are designed with an albumin-binding motif that can alter duration in experimental systems. No-DAC forms are shorter-acting analogs related to modified GRF 1-29. Always verify the exact product identity on the COA.
